IPEIX
Price
$6.53
Change
+$0.03 (+0.46%)
Updated
Jan 17 closing price
Net Assets
594.59M
VIVIX
Price
$68.15
Change
+$0.43 (+0.63%)
Updated
Jan 17 closing price
Net Assets
183.52B
Ad is loading...

IPEIX vs VIVIX

Header iconIPEIX vs VIVIX Comparison
Open Charts IPEIX vs VIVIXBanner chart's image
Voya Large Cap Value Port I
Price$6.53
Change+$0.03 (+0.46%)
VolumeN/A
Net Assets594.59M
Vanguard Value Index I
Price$68.15
Change+$0.43 (+0.63%)
VolumeN/A
Net Assets183.52B
IPEIX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IPEIX vs. VIVIX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPEIX is a Buy and VIVIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. IPEIX (595M). VIVIX pays higher dividends than IPEIX: VIVIX (2.37) vs IPEIX (1.23). IPEIX was incepted earlier than VIVIX: IPEIX (18 years) vs VIVIX (27 years). IPEIX has a lower initial minimum investment than VIVIX: IPEIX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 18.21 vs. IPEIX (15.07). VIVIX return over 5 years is better than : 44.19 vs. IPEIX (-42.70).
IPEIXVIVIXIPEIX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years27 years-
Gain YTD2.8353.21188%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets595M184B0%
Annual Yield % from dividends1.232.3752%
Returns for 1 year15.0718.2183%
Returns for 3 years-51.5218.46-279%
Returns for 5 years-42.7044.19-97%
Returns for 10 years-35.35111.13-32%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMR192.652.55
+1.34%
Alpha Metallurgical Resources
BV15.980.19
+1.20%
BrightView Holdings
HPQ32.510.16
+0.49%
HP
OBT26.55-0.18
-0.67%
Orange County Bancorp Inc
CGTX0.68-0.01
-1.80%
Cognition Therapeutics